Condition: CRC (Colorectal Cancer) · Sponsor: Incyte Corporation
The purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer.
This description comes directly from the study's public registry record.
Incyte Corporation Call Center (US) · 1.855.463.3463 · medinfo@incyte.com
Incyte Corporation Call Center (ex-US) · +800 00027423 · eumedinfo@incyte.com
Always discuss trial participation with your own doctor first.
| The University of Arizona Cancer Center | Tucson, Arizona, United States | Not Yet Recruiting |
| Roche Tissue Diagnostics, Companion Diagnostics | Tucson, Arizona, United States | Recruiting |
| Memorial Care Orange Coast Medical Center | Fountain Valley, California, United States | Recruiting |
| Providence Medical Foundation | Fullerton, California, United States | Recruiting |
| Cancer & Blood Research Center | Los Alamitos, California, United States | Recruiting |
| University of California Los Angeles Health | Los Angeles, California, United States | Not Yet Recruiting |
| Sarah Cannon Research Institute Scri Oncology Partners | Aurora, Colorado, United States | Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Not Yet Recruiting |
| George Washington University | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| Florida Oncology & Hematology | Fort Myers, Florida, United States | Recruiting |
| University of Florida Health | Gainesville, Florida, United States | Not Yet Recruiting |
| Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Recruiting |
+ 243 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07284849